Temporal Trends in Infarct Severity Outcomes in ST-Segment-Elevation Myocardial Infarction: A Cardiac Magnetic

Ivan Lechner1, Martin Reindl1, Christina Tiller1

  • 1University Clinic of Internal Medicine III, Cardiology and Angiology Medical University of Innsbruck Innsbruck Austria.

Insights

Despite advancements in treatment for ST-segment-elevation myocardial infarction (STEMI), cardiac magnetic resonance imaging shows no significant change in myocardial infarct size or severity over 15 years. Further research into novel therapies is crucial to reduce heart tissue damage.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Clinical Research

Background:

  • Myocardial tissue injury severity significantly impacts morbidity and mortality in ST-segment-elevation myocardial infarction (STEMI).
  • Temporal trends in myocardial infarct characteristics at the tissue level remain undescribed.
  • Cardiac magnetic resonance imaging (CMR) provides comprehensive assessment of myocardial tissue injury.

Purpose of the Study:

  • To assess temporal trends in infarct characteristics using CMR at a standardized early time point after STEMI.
  • To evaluate changes in infarct size, microvascular obstruction, and intramyocardial hemorrhage over time.
  • To investigate long-term outcomes and left ventricular remodeling in STEMI patients.

Main Methods:

  • Analysis of 843 STEMI patients treated with percutaneous coronary intervention (PCI) between 2005 and 2021.
  • Utilized a multiparametric CMR protocol within the first week post-STEMI.
  • Compared infarct characteristics and clinical outcomes across three study period terciles.

Main Results:

  • No significant changes observed in infarct size (P=0.25), microvascular obstruction (P=0.50), or intramyocardial hemorrhage (P=0.34) over the study period.
  • Left ventricular remodeling indices and ejection fraction remained unchanged (all P>0.05).
  • Major adverse cardiovascular events at 4 months were similar across groups (P=0.36).

Conclusions:

  • Despite advancements in PCI and guideline-recommended therapies, myocardial infarct severity has not improved over the past 15 years.
  • Current therapeutic approaches may not be sufficient to reduce myocardial tissue injury in STEMI.
  • Prioritizing clinical research for novel therapeutic strategies to mitigate myocardial damage is essential.